CD8A and neoplasm: Recently, studies have found that the presence of Tfh cells is important for upregulating CD8-dependent anti-tumor immunity and improving the benefit of anti-PD-L1 therapy in tumors (Chen et al., 2021; Niogret et al., 2021).